A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

Clinical trial NCT06924827 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06924827
Sponsor: Elizabeth Donner
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)

Start date: 2026-06-01
Primary completion: 2028-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.